This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Infectious Disease Research Institute, Mogam Institute for Biomedical Research. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021
Title: Innovations of Kang Il Yoo in Vaccine Development.
Introduction
Kang Il Yoo is a notable inventor from South Korea, recognized for his contributions to vaccine development. His work primarily focuses on enhancing the safety and efficacy of vaccines, particularly in relation to herpes zoster.
Latest Patents
Kang Il Yoo holds a patent for a herpes zoster vaccine composition. This innovative composition includes glycoprotein E of the Varicella zoster virus, a glucopyranosyl lipid adjuvant, and a metabolic oil. The formulation is designed to selectively increase a cell-mediated immune reaction while avoiding the disadvantages associated with attenuated live vaccines. This approach aims to provide high safety and a significant preventive effect against herpes zoster.
Career Highlights
Throughout his career, Kang Il Yoo has focused on developing advanced vaccine technologies. His research has contributed to the understanding of immune responses and the formulation of safer vaccine alternatives. His work is pivotal in the ongoing efforts to improve public health through effective vaccination strategies.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Kang Il Yoo's innovative work in vaccine development, particularly with his herpes zoster vaccine composition, showcases his commitment to enhancing public health through scientific advancements. His contributions are significant in the field of immunology and vaccine research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile